D.A. Davidson & Co’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
65,000
-4,500
-6% -$16.4K ﹤0.01% 1454
2026
Q1
$275K Hold
69,500
﹤0.01% 1386
2025
Q4
$471K Sell
69,500
-2,000
-3% -$14K ﹤0.01% 1169
2025
Q3
$499K Sell
71,500
-15,000
-17% -$104K ﹤0.01% 1132
2025
Q2
$529K Sell
86,500
-9,000
-9% -$59.9K ﹤0.01% 1028
2025
Q1
$726K Sell
95,500
-15,400
-14% -$129K 0.01% 884
2024
Q4
$1.07M Sell
110,900
-4,500
-4% -$35.1K 0.01% 742
2024
Q3
$682K Sell
115,400
-6,500
-5% -$43.1K 0.01% 904
2024
Q2
$845K Buy
121,900
+2,000
+2% +$14.1K 0.01% 791
2024
Q1
$923K Hold
119,900
0.01% 765
2023
Q4
$1.05M Hold
119,900
0.01% 696
2023
Q3
$874K Sell
119,900
-4,500
-4% -$33.5K 0.01% 715
2023
Q2
$822K Hold
124,400
0.01% 750
2023
Q1
$424K Buy
124,400
+3,000
+2% +$11.6K ﹤0.01% 940
2022
Q4
$337K Buy
121,400
+12,000
+11% +$35.9K ﹤0.01% 1001
2022
Q3
$314K Sell
109,400
-12,000
-10% -$42.6K ﹤0.01% 982
2022
Q2
$421K Hold
121,400
0.01% 881
2022
Q1
$572K Hold
121,400
0.01% 837
2021
Q4
$733K Hold
121,400
0.01% 740
2021
Q3
$736K Sell
121,400
-40,000
-25% -$451K 0.01% 716
2021
Q2
$2.02M Buy
161,400
+24,000
+17% +$260K 0.02% 429
2021
Q1
$1.42M Buy
137,400
+20,000
+17% +$193K 0.02% 486
2020
Q4
$1.07M Buy
+117,400
New +$845K 0.02% 495
2018
Q4
Sell
-161,400
Closed -$997K 1141
2018
Q3
$997K Buy
161,400
+51,500
+47% +$233K 0.02% 511
2018
Q2
$702K Buy
109,900
+18,000
+20% +$128K 0.01% 607
2018
Q1
$641K Buy
91,900
+67,900
+283% +$791K 0.01% 604
2017
Q4
$303K Buy
24,000
+10,000
+71% +$122K 0.01% 844
2017
Q3
$166K Buy
+14,000
New +$208K ﹤0.01% 1036

Other funds holding MDXG

D.A. Davidson & Co's MDXG Position: Q2 2026 in Review

D.A. Davidson & Co reduced its MiMedx Group (MDXG) stake by 6.5% in Q2 2026, selling an estimated $16.4K and leaving 65,000 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

D.A. Davidson & Co first reported a position in MDXG in Q3 2017 and has held it in 28 quarters since. The position peaked at $2.02M in Q2 2021. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • D.A. Davidson & Co held 65,000 shares of MiMedx Group worth $250K as of Q2 2026.
  • D.A. Davidson & Co sold 4,500 MiMedx Group shares in Q2 2026, an estimated $16.4K.
  • MiMedx Group made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1454 holding.
  • D.A. Davidson & Co first reported a position in MiMedx Group in Q3 2017 and has held it in 28 quarters since.
  • D.A. Davidson & Co's MiMedx Group position peaked at $2.02M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.